XBiotech Inc. (XBIT)
XBIT Stock Price Chart
Explore XBiotech Inc. interactive price chart. Choose custom timeframes to analyze XBIT price movements and trends.
XBIT Company Profile
Discover essential business fundamentals and corporate details for XBiotech Inc. (XBIT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Apr 2015
Employees
92.00
Website
https://www.xbiotech.comCEO
John Simard
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
XBIT Financial Timeline
Browse a chronological timeline of XBiotech Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 11 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.06 .
Earnings released on 14 May 2025
EPS came in at -$0.36 .
Earnings released on 18 Mar 2025
EPS came in at -$0.34 .
Earnings released on 13 Nov 2024
EPS came in at -$0.16 .
Earnings released on 12 Aug 2024
EPS came in at -$0.43 .
Earnings released on 10 May 2024
EPS came in at -$0.33 .
Earnings released on 15 Mar 2024
EPS came in at -$0.16 , while revenue for the quarter reached $2.62M , missing expectations by -62.57%.
Earnings released on 9 Nov 2023
EPS came in at -$0.24 .
Earnings released on 11 Aug 2023
EPS came in at -$0.29 .
Earnings released on 10 May 2023
EPS came in at -$0.13 .
Earnings released on 15 Mar 2023
EPS came in at -$0.10 , while revenue for the quarter reached $300.00K , missing expectations by -95.71%.
Earnings released on 9 Nov 2022
EPS came in at -$0.42 , while revenue for the quarter reached $1.68M .
Earnings released on 10 Aug 2022
EPS came in at -$0.38 , while revenue for the quarter reached $1.53M , missing expectations by -78.14%.
Earnings released on 10 May 2022
EPS came in at -$0.18 , while revenue for the quarter reached $500.00K , missing expectations by -92.86%.
Earnings released on 15 Mar 2022
EPS came in at -$0.21 falling short of the estimated $0.02 by -1.15K%, while revenue for the quarter reached $4.50M , missing expectations by -35.71%.
Earnings released on 9 Nov 2021
EPS came in at -$0.11 falling short of the estimated $0.03 by -466.67%, while revenue for the quarter reached $4.52M , missing expectations by -35.44%.
Earnings released on 9 Aug 2021
EPS came in at -$0.17 falling short of the estimated $0.03 by -666.67%, while revenue for the quarter reached $4.53M , missing expectations by -35.36%.
Dividend declared on 6 Jul 2021
A dividend of $2.50 per share was announced, adjusted to $2.47. The dividend was paid on 23 Jul 2021.
Earnings released on 10 May 2021
EPS came in at -$0.09 falling short of the estimated $0.04 by -325.00%, while revenue for the quarter reached $4.85M , missing expectations by -30.71%.
Earnings released on 16 Mar 2021
EPS came in at -$0.06 falling short of the estimated $0.04 by -250.00%, while revenue for the quarter reached $5.27M , missing expectations by -24.73%.
Earnings released on 9 Nov 2020
EPS came in at -$0.09 falling short of the estimated $0.04 by -325.00%, while revenue for the quarter reached $10.55M , beating expectations by +50.70%.
XBIT Stock Performance
Access detailed XBIT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.